Aadi Historical Balance Sheet

AADI Stock

USD 2.30 0.02 0.88%

Trend analysis of Aadi Bioscience balance sheet accounts such as Total Stockholder Equity of 110.5 M, Cash of 66 M or Cash And Short Term Investments of 114.3 M provides information on Aadi Bioscience's total assets, liabilities, and equity, which is the actual value of Aadi Bioscience to its prevalent stockholders. By breaking down trends over time using Aadi Bioscience balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Aadi Bioscience latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Aadi Bioscience is a good buy for the upcoming year.

Aadi Bioscience Inventory

6.75 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.

About Aadi Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Aadi Bioscience at a specified time, usually calculated after every quarter, six months, or one year. Aadi Bioscience Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Aadi Bioscience and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Aadi currently owns. An asset can also be divided into two categories, current and non-current.

Aadi Bioscience Balance Sheet Chart

As of now, Aadi Bioscience's Cash And Short Term Investments are increasing as compared to previous years. The Aadi Bioscience's current Common Stock Shares Outstanding is estimated to increase to about 28.3 M, while Net Debt is forecasted to increase to (58.5 M).

Total Assets Cash And Short Term Investments Common Stock Shares Outstanding Other Stockholder Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Aadi Bioscience assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Aadi Bioscience books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Aadi Bioscience balance sheet. This account contains Aadi Bioscience investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Aadi Bioscience fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Most accounts from Aadi Bioscience's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Aadi Bioscience current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.As of now, Aadi Bioscience's Cash And Short Term Investments are increasing as compared to previous years. The Aadi Bioscience's current Common Stock Shares Outstanding is estimated to increase to about 28.3 M, while Net Debt is forecasted to increase to (58.5 M).

	2021	2022	2023	2024 (projected)
Total Current Assets	151.3M	180.0M	124.6M	130.8M
Other Stockholder Equity	279.1M	361.7M	374.1M	392.8M

Total Current Assets Other Stockholder Equity

Aadi Bioscience balance sheet Correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Current Assets	Short Long Term Debt Total	Total Current Liabilities	Other Assets	Non Current Liabilities Total	Total Liab	Short Term Debt	Common Stock	Other Current Liab	Accounts Payable	Other Current Assets	Non Current Assets Total	Non Currrent Assets Other	Property Plant And Equipment Net	Current Deferred Revenue	Short Term Investments	Common Stock Total Equity	Property Plant And Equipment Gross
Total Assets		0.99	-0.79	-0.85	0.8	1.0	0.84	0.95	1.0	-0.11	0.65	0.93	0.81	0.73	-0.21	0.45	0.88	0.88	0.96	0.88	0.96	0.67	0.74	0.73	-0.39	0.66
Total Stockholder Equity	0.99		-0.81	-0.83	0.81	1.0	0.8	0.94	0.99	-0.23	0.53	0.9	0.8	0.63	-0.32	0.48	0.85	0.83	0.95	0.85	0.95	0.63	0.7	0.73	-0.44	0.62
Net Debt	-0.79	-0.81		0.63	-1.0	-0.8	-0.45	-0.74	-0.78	0.28	-0.35	-0.69	-0.62	-0.43	0.33	-0.56	-0.58	-0.77	-0.83	-0.72	-0.75	-0.38	-0.66	-0.19	0.26	-0.37
Retained Earnings	-0.85	-0.83	0.63		-0.66	-0.83	-0.85	-0.95	-0.85	0.0	-0.68	-0.83	-0.44	-0.7	0.1	-0.56	-0.93	-0.8	-0.85	-0.84	-0.8	-0.82	-0.8	-0.61	0.27	-0.81
Cash	0.8	0.81	-1.0	-0.66		0.81	0.48	0.75	0.8	-0.19	0.42	0.72	0.63	0.5	-0.25	0.54	0.61	0.8	0.84	0.75	0.76	0.4	0.68	0.2	-0.24	0.4
Cash And Short Term Investments	1.0	1.0	-0.8	-0.83	0.81		0.79	0.93	1.0	-0.15	0.58	0.9	0.83	0.68	-0.24	0.47	0.84	0.84	0.95	0.84	0.95	0.61	0.72	0.73	-0.41	0.6
Common Stock Shares Outstanding	0.84	0.8	-0.45	-0.85	0.48	0.79		0.88	0.83	-0.05	0.7	0.93	0.48	0.72	-0.17	0.19	0.97	0.82	0.83	0.91	0.87	0.94	0.58	0.75	-0.46	0.94
Other Stockholder Equity	0.95	0.94	-0.74	-0.95	0.75	0.93	0.88		0.95	-0.16	0.64	0.91	0.6	0.69	-0.26	0.58	0.94	0.86	0.93	0.89	0.9	0.79	0.82	0.68	-0.31	0.79
Total Current Assets	1.0	0.99	-0.78	-0.85	0.8	1.0	0.83	0.95		-0.11	0.64	0.93	0.81	0.73	-0.21	0.46	0.87	0.87	0.96	0.87	0.95	0.66	0.74	0.74	-0.38	0.65
Short Long Term Debt Total	-0.11	-0.23	0.28	0.0	-0.19	-0.15	-0.05	-0.16	-0.11		0.55	-0.05	-0.02	0.5	0.99	-0.28	-0.05	0.02	-0.14	-0.07	-0.11	-0.03	0.02	-0.03	0.31	-0.03
Total Current Liabilities	0.65	0.53	-0.35	-0.68	0.42	0.58	0.7	0.64	0.64	0.55		0.72	0.43	0.99	0.44	0.13	0.71	0.79	0.61	0.7	0.63	0.68	0.68	0.47	0.02	0.68
Other Assets	0.93	0.9	-0.69	-0.83	0.72	0.9	0.93	0.91	0.93	-0.05	0.72		0.69	0.78	-0.17	0.21	0.94	0.95	0.95	0.98	0.98	0.83	0.63	0.67	-0.51	0.83
Non Current Liabilities Total	0.81	0.8	-0.62	-0.44	0.63	0.83	0.48	0.6	0.81	-0.02	0.43	0.69		0.57	-0.07	0.16	0.47	0.63	0.73	0.56	0.78	0.19	0.44	0.68	-0.4	0.18
Total Liab	0.73	0.63	-0.43	-0.7	0.5	0.68	0.72	0.69	0.73	0.5	0.99	0.78	0.57		0.39	0.15	0.73	0.83	0.69	0.74	0.71	0.65	0.7	0.55	-0.05	0.65
Short Term Debt	-0.21	-0.32	0.33	0.1	-0.25	-0.24	-0.17	-0.26	-0.21	0.99	0.44	-0.17	-0.07	0.39		-0.3	-0.17	-0.09	-0.23	-0.19	-0.22	-0.15	-0.07	-0.11	0.32	-0.15
Common Stock	0.45	0.48	-0.56	-0.56	0.54	0.47	0.19	0.58	0.46	-0.28	0.13	0.21	0.16	0.15	-0.3		0.33	0.29	0.36	0.22	0.23	0.17	0.78	0.16	0.3	0.17
Other Current Liab	0.88	0.85	-0.58	-0.93	0.61	0.84	0.97	0.94	0.87	-0.05	0.71	0.94	0.47	0.73	-0.17	0.33		0.86	0.89	0.94	0.89	0.93	0.67	0.68	-0.42	0.93
Accounts Payable	0.88	0.83	-0.77	-0.8	0.8	0.84	0.82	0.86	0.87	0.02	0.79	0.95	0.63	0.83	-0.09	0.29	0.86		0.91	0.96	0.92	0.77	0.74	0.47	-0.35	0.77
Other Current Assets	0.96	0.95	-0.83	-0.85	0.84	0.95	0.83	0.93	0.96	-0.14	0.61	0.95	0.73	0.69	-0.23	0.36	0.89	0.91		0.94	0.97	0.72	0.66	0.61	-0.49	0.72
Non Current Assets Total	0.88	0.85	-0.72	-0.84	0.75	0.84	0.91	0.89	0.87	-0.07	0.7	0.98	0.56	0.74	-0.19	0.22	0.94	0.96	0.94		0.95	0.87	0.62	0.53	-0.5	0.87
Non Currrent Assets Other	0.96	0.95	-0.75	-0.8	0.76	0.95	0.87	0.9	0.95	-0.11	0.63	0.98	0.78	0.71	-0.22	0.23	0.89	0.92	0.97	0.95		0.73	0.6	0.69	-0.58	0.73
Property Plant And Equipment Net	0.67	0.63	-0.38	-0.82	0.4	0.61	0.94	0.79	0.66	-0.03	0.68	0.83	0.19	0.65	-0.15	0.17	0.93	0.77	0.72	0.87	0.73		0.54	0.52	-0.36	1.0
Current Deferred Revenue	0.74	0.7	-0.66	-0.8	0.68	0.72	0.58	0.82	0.74	0.02	0.68	0.63	0.44	0.7	-0.07	0.78	0.67	0.74	0.66	0.62	0.6	0.54		0.41	0.16	0.54
Short Term Investments	0.73	0.73	-0.19	-0.61	0.2	0.73	0.75	0.68	0.74	-0.03	0.47	0.67	0.68	0.55	-0.11	0.16	0.68	0.47	0.61	0.53	0.69	0.52	0.41		-0.41	0.51
Common Stock Total Equity	-0.39	-0.44	0.26	0.27	-0.24	-0.41	-0.46	-0.31	-0.38	0.31	0.02	-0.51	-0.4	-0.05	0.32	0.3	-0.42	-0.35	-0.49	-0.5	-0.58	-0.36	0.16	-0.41		-0.35
Property Plant And Equipment Gross	0.66	0.62	-0.37	-0.81	0.4	0.6	0.94	0.79	0.65	-0.03	0.68	0.83	0.18	0.65	-0.15	0.17	0.93	0.77	0.72	0.87	0.73	1.0	0.54	0.51	-0.35

Click cells to compare fundamentals

Aadi Bioscience Account Relationship Matchups

Aadi Bioscience balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	39.9M	18.8M	157.9M	184.2M	132.4M	139.0M
Total Stockholder Equity	36.5M	(12.4M)	136.4M	158.4M	105.2M	110.5M
Net Debt	(38.4M)	5.8M	(148.4M)	(37.4M)	(61.6M)	(58.5M)
Retained Earnings	(142.2M)	(32.6M)	(142.7M)	(203.2M)	(269.0M)	(255.5M)
Cash	38.5M	4.5M	149.0M	39.0M	62.9M	66.0M
Cash And Short Term Investments	38.5M	4.5M	149.0M	172.6M	108.8M	114.3M
Common Stock Shares Outstanding	2.7M	2.5M	8.9M	22.5M	26.9M	28.3M
Liabilities And Stockholders Equity	39.9M	18.8M	157.9M	184.2M	132.4M	139.0M
Other Stockholder Equity	179.1M	20.2M	279.1M	361.7M	374.1M	392.8M
Total Current Assets	39.6M	18.7M	151.3M	180.0M	124.6M	130.8M
Total Current Liabilities	3.3M	30.1M	15.3M	18.8M	26.4M	27.7M
Total Liab	3.4M	31.3M	21.5M	25.9M	27.2M	28.6M
Other Current Liab	2.8M	99K	8.7M	14.5M	20.1M	21.1M
Accounts Payable	439.8K	2.4M	6.4M	3.5M	5.9M	6.2M
Other Current Assets	1.0M	81K	4.6M	3.7M	3.8M	4.0M
Non Current Assets Total	366.3K	140K	6.6M	4.2M	7.8M	8.2M
Non Currrent Assets Other	40.0K	(140K)	2.2M	2.1M	1.9M	2.0M
Property Plant And Equipment Net	326.3K	140K	614K	2.0M	6.0M	6.3M
Accumulated Other Comprehensive Income	(335.8K)	(311.1K)	(328.9K)	(115K)	27K	28.4K
Property Plant And Equipment Gross	326.3K	185.6K	614K	2.0M	6.2M	6.6M
Net Tangible Assets	(9.1M)	43.1M	132.6M	158.4M	182.1M	191.2M
Property Plant Equipment	316.0K	121.7K	57K	2.0M	2.3M	2.5M

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether Aadi Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aadi Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aadi Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aadi Bioscience Stock:

How To Invest In Aadi

Details

Is Aadi Stock a good investment?

Details

What is Aadi Bioscience's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.

You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.28)

Revenue Per Share

0.929

Quarterly Revenue Growth

0.21

Return On Assets

(0.35)

Return On Equity

(0.66)

The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Aadi Historical Balance Sheet

Aadi Bioscience Inventory

6.75 Million

About Aadi Balance Sheet Analysis

Aadi Bioscience Balance Sheet Chart

Total Assets

Cash And Short Term Investments

Common Stock Shares Outstanding

Aadi Bioscience balance sheet Correlations

Aadi Bioscience Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Aadi Bioscience balance sheet Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Cash And Short Term Investments
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Stockholder Equity	+ 0.99	Total Assets

Cash	- 1.0	Net Debt
Other Stockholder Equity	- 0.95	Retained Earnings
Other Current Liab	- 0.93	Retained Earnings
Other Current Assets	- 0.85	Retained Earnings
Total Current Assets	- 0.85	Retained Earnings
Common Stock Shares Outstanding	- 0.85	Retained Earnings